Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 2 days agoIt’s the first trial of an Alzheimer’s treatment that explores potentially stopping and...
‘Reversing’ Alzheimer’s: Here are exercises to make the brain more resilient
Fox News via Yahoo News· 2 days agoIn her new book “Reversing Alzheimer's: The New Tool Kit to Improve Cognition and Protect Brain...
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 3 days agoDonanemab is an Aβ targeting therapy. Aβ is a protein that is said to be the primary cause...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 20 hours agoBoth Leqembi and donanemab are Aβ targeting therapies. Aβ is a protein that is said to...
Washington County Sports Hall of Fame Class of 1989
Gannett via AOL· 1 day ago“For 20 years, McNeal served as a minor league instructor at the Orioles' spring training camps in Florida. For eight seasons, he was under contract to...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 3 days agoThe trial studied the drug's ability to address beta-amyloid plaque buildup associated with dementia...
Doran School playground dedicated to former Fall River City Councilor Alfredo P. Alves
The Herald News via Yahoo News· 1 day agoAs a tribute to his dedication and commitment to the school, a plaque was unveiled at the...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via Yahoo News· 3 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the progression of early ...
Country’s first documented gay rights organization started 100 years ago in Old Town
Chicago Tribune via Yahoo News· 5 days agoA century ago, Henry Gerber founded America’s first documented gay rights organization in a...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
KOLD News 13 Tuscon· 3 days agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia ...